Related Experiment Videos
Risk factors in primary sclerosing cholangitis
E Schrumpf1, M Abdelnoor, O Fausa
1Medical Department, Rikshospitalet, Oslo, Norway.
Journal of Hepatology
|December 1, 1994
Summary
Primary sclerosing cholangitis prognosis is influenced by bilirubin levels and age at diagnosis. Female patients show poorer survival rates, and cholangiocarcinoma is a significant concern.
Area of Science:
- Hepatology
- Gastroenterology
- Transplant Surgery
Background:
- Primary sclerosing cholangitis (PSC) management necessitates accurate prognostic indicators due to increased liver transplantation and evolving treatments.
- Understanding PSC's natural history is crucial for patient care and clinical decision-making.
Purpose of the Study:
- To clarify the natural history and prognosis of primary sclerosing cholangitis.
- To identify clinical features at presentation that predict outcomes in PSC patients.
Main Methods:
- Retrospective analysis of 77 consecutive primary sclerosing cholangitis patients.
- Evaluation of clinical features, concomitant diseases, and follow-up data.
- Assessment of mortality, liver transplantation, and cholangiocarcinoma incidence.
Main Results:
- Median age at diagnosis was 32.5 years; 66% were male; 76% had inflammatory bowel disease.
- Cholangiocarcinoma diagnosed in 14% of patients; 25 patients died or underwent transplantation over a mean 6.2-year follow-up.
- Elevated bilirubin and older age at diagnosis were independent risk factors for mortality/transplantation and cholangiocarcinoma.
Conclusions:
- Bilirubin level is a critical independent prognostic factor for mortality, transplantation, and cholangiocarcinoma in PSC.
- Female sex is associated with poorer survival in PSC.
- Prognostic indices may have limited value for individualizing transplant timing due to bilirubin's strong predictive power.